Results 11 to 20 of about 483,002 (343)
Do Activist Hedge Funds Target Female CEOs? The Role of CEO Gender in Hedge Fund Activism
Journal of Financial Economics, 2019 Using a comprehensive hedge fund activism dataset, we find that activist hedge funds are about 52% more likely to target firms with female CEOs compared to firms with male CEOs.
Bill Francis +3 more
semanticscholar +1 more source
Hedge Funds and Stock Price Formation
Financial analysts journal, 2018 Using comprehensive quarterly data on hedge fund stock holdings, we study the role of hedge funds in the process of stock price formation. We find that hedge funds tend to hold undervalued stocks and that both hedge fund ownership and trading by hedge ...
C. Cao +3 more
semanticscholar +2 more sources
Costs and Benefits of Financial Conglomerate Affiliation: Evidence from Hedge Funds
Journal of Financial Economics, 2018 This paper explores how affiliation to financial conglomerates affects asset managers’ access to capital, risk taking, and performance. Focusing on a sample of hedge funds, we find that financial conglomerate-affiliated hedge funds (FCAHFs) have lower ...
Francesco Franzoni +1 more
semanticscholar +1 more source
Liquidity Transformation and Financial Fragility: Evidence from Funds of Hedge Funds
Journal of Financial and Quantitative Analysis, 2018 We examine liquidity transformation by funds of hedge funds (FoFs) by developing a new measure, illiquidity gap, that captures the mismatch between the liquidity of their portfolios and the liquidity available to their investors.
V. Agarwal, George O. Aragon, Zhen Shi
semanticscholar +1 more source
Do Alpha Males Deliver Alpha? Facial Width-to-Height Ratio and Hedge Funds
Journal of Financial and Quantitative Analysis, 2018 An abundance of evidence relates facial width-to-height ratio (fWHR) to masculine behaviors in males. We show that hedge funds operated by high-fWHR managers underperform those operated by low-fWHR managers, bear greater downside risk, are more ...
Yan Lu, Melvyn Teo
semanticscholar +1 more source
FEBS Letters, EarlyView.In this study, we present the structure of AcrIE8.1, a previously uncharacterized anti‐CRISPR protein that inhibits the type I‐E CRISPR‐Cas system. Through a combination of structural and biochemical analyses, we demonstrate that AcrIE8.1 directly binds to the Cas11 subunit of the Cascade complex to inhibit the CRISPR‐Cas system.
Young Woo Kang, Hyun Ho Park
wiley +1 more source
Waking up to hedge funds : is U.S. regulation taking a new direction? [PDF]
, 2003 In response to recent developments in the financial markets and the stunning growth of the hedge fund industry in the United States, policy makers, most notably the Securities and Exchange Commission (“SEC”), are turning their attention to the regulation,
MacHarg, Marcia L.
core
By dawn or dusk—how circadian timing rewrites bacterial infection outcomes
FEBS Letters, EarlyView.The circadian clock shapes immune function, yet its influence on infection outcomes is only beginning to be understood. This review highlights how circadian timing alters host responses to the bacterial pathogens Salmonella enterica, Listeria monocytogenes, and Streptococcus pneumoniae revealing that the effectiveness of immune defense depends not only
Devons Mo +2 more
wiley +1 more source
Evaluating hedge fund performance: a stochastic dominance approach [PDF]
, 2007 We introduce a general and flexible framework for hedge fund performance evaluation and asset allocation: stochastic dominance (SD) theory. Our approach utilizes statistical tests for stochastic dominance to compare the returns of hedge funds.
Li, Sheng, Linton, Oliver
core
Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?
FEBS Letters, EarlyView.This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes +3 more
wiley +1 more source